Retour
Prix ABIVAX Société Anonyme (ABVX)
Graphique du cours de l'action ABVX
ABVX Prix
ABIVAX Société Anonyme
$120.34
-2.18%
$-2.68
À la fermeture : Mar 20, 16:00:00 GMT-4
$117.43
-2.41%
$-2.9
Post-Marché: Mar 20, 20:00:00 GMT-4
Statistiques clés
Clôture préc.
$123.02
Prix d'ouverture
$123.95
Plage de la journée
$117.43 - $126.86
Plage de 52 semaines
$4.77 - $148.83
Volume
1.3M
Volume moyen
1.2M
Rendement en dividend
--
BPA (TTM)
-5.08
Capitalisation boursière
$9.2B
Qu’est-ce que Abivax SA ?
Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 69 full-time employees. The company went IPO on 2015-06-26. ABIVAX utilizes RNA-protein interaction interference and cytotoxic TH1 cell amplification to generate therapies to help patients clear viruses like HIV, HBV and HPV. The firm's product pipeline comprises ABX 203, which is the therapeutic vaccine candidate obtained from the Centre for Genetic Engineering and Biotechnology, Cuba (CIGB) and is intended for patients with chronic hepatitis B disease; and ABX196, the adjuvant for therapeutic vaccines, among others.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.
